2-(2'-Hydroxytetracosanoylamino)-octadecane-1,3,4-triolCAS# 154801-30-6 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 154801-30-6 | SDF | Download SDF |
PubChem ID | 25203220 | Appearance | Powder |
Formula | C42H85NO5 | M.Wt | 684.1 |
Type of Compound | Cerebrosides | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | 2-hydroxy-N-(1,3,4-trihydroxyoctadecan-2-yl)tetracosanamide | ||
SMILES | CCCCCCCCCCCCCCCCCCCCCCC(C(=O)NC(CO)C(C(CCCCCCCCCCCCCC)O)O)O | ||
Standard InChIKey | ZFUXWVVVWGWGPQ-UHFFFAOYSA-N | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. (2S,3S,4R,2′R)-2-(2′-hydroxytetracosanoylamino)octadecane-1,3,4-triol shows selectively inhibitory activity against phospholipase A 2 (PLA 2) secreted from Crotalus adamenteus venom at concentration of 100 ug/mL. |
Targets | Phospholipase (e.g. PLA) |
2-(2'-Hydroxytetracosanoylamino)-octadecane-1,3,4-triol Dilution Calculator
2-(2'-Hydroxytetracosanoylamino)-octadecane-1,3,4-triol Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 1.4618 mL | 7.3089 mL | 14.6177 mL | 29.2355 mL | 36.5444 mL |
5 mM | 0.2924 mL | 1.4618 mL | 2.9235 mL | 5.8471 mL | 7.3089 mL |
10 mM | 0.1462 mL | 0.7309 mL | 1.4618 mL | 2.9235 mL | 3.6544 mL |
50 mM | 0.0292 mL | 0.1462 mL | 0.2924 mL | 0.5847 mL | 0.7309 mL |
100 mM | 0.0146 mL | 0.0731 mL | 0.1462 mL | 0.2924 mL | 0.3654 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- 3-Methoxymollugin
Catalog No.:BCN7164
CAS No.:154706-44-2
- Tezampanel
Catalog No.:BCC1993
CAS No.:154652-83-2
- Efavirenz
Catalog No.:BCC4135
CAS No.:154598-52-4
- Stauprimide
Catalog No.:BCC7768
CAS No.:154589-96-5
- SB 204990
Catalog No.:BCC6342
CAS No.:154566-12-8
- CHM 1
Catalog No.:BCC2387
CAS No.:154554-41-3
- Sinapaldehyde glucoside
Catalog No.:BCN1689
CAS No.:154461-65-1
- Methyl 5-O-feruloylquinate
Catalog No.:BCN3402
CAS No.:154461-64-0
- LY 303511
Catalog No.:BCC1715
CAS No.:154447-38-8
- LY 294002
Catalog No.:BCC3659
CAS No.:154447-36-6
- NU 7026
Catalog No.:BCC3933
CAS No.:154447-35-5
- Fmoc-Arg(Pbf)-OH
Catalog No.:BCC3040
CAS No.:154445-77-9
- Cimiside E
Catalog No.:BCN7951
CAS No.:154822-57-8
- 4-Acetoxycinnamic acid
Catalog No.:BCN5026
CAS No.:15486-19-8
- Eleutheroside C
Catalog No.:BCN1690
CAS No.:15486-24-5
- 3,5-Dihydroxy-4',7-dimethoxyflavone
Catalog No.:BCN1691
CAS No.:15486-33-6
- Kaempferol 3,7,4'-trimethylether
Catalog No.:BCN4087
CAS No.:15486-34-7
- LL 37
Catalog No.:BCC8027
CAS No.:154947-66-7
- BAY-u 9773
Catalog No.:BCC7576
CAS No.:154978-38-8
- Erysenegalensein E
Catalog No.:BCN3979
CAS No.:154992-17-3
- RU 58841
Catalog No.:BCC1911
CAS No.:154992-24-2
- Methscopolamine
Catalog No.:BCC4577
CAS No.:155-41-9
- Rhaponiticin
Catalog No.:BCN5392
CAS No.:155-58-8
- Ac-Arg-OH.2H2O
Catalog No.:BCC2855
CAS No.:155-84-0
A new ceramide from the basidiomycete Russula cyanoxantha.[Pubmed:11269698]
Lipids. 2001 Feb;36(2):175-80.
A new phytosphingosine-type ceramide (1) was isolated along with nine other compounds-5alpha,8alpha-epidioxy(22E,24R)-ergosta-6,22-dien-3beta-ol, 5alpha,8alpha-epidioxy-(24S)-ergosta-6-en-3beta-ol, (24S)-ergosta-7-ene-3beta,5alpha,6beta-triol, (22E,24R)-ergosta-7,22-dien-3beta,5alpha,6beta-triol, inosine, adenine, L-pyroglutamic acid, fumaric acid, and D-allitol from the ethanol and chloroform/methanol extract of the fruiting bodies of the basidiomycete Russula cyanoxanotha (Schaeff.) Fr. The structure of (1) was established as (2S,3S,4R,2'R)-2-(2'-hydroxytetracosanoylamino) octadecane-1,3,4-triol by means of spectroscopic and chemical methods.